BC Platforms delivers data platform for UK research consortium to improve detection of lung cancer
ZURICH and LONDON, Dec. 18, 2020 /PRNewswire/ BC Platforms, a global leader in clinical and genomic data management, analytics and access, today announced it is providing its discovery and research platform BC|INSIGHT to enable ground-breaking medical research into the early diagnosis of lung cancer in order to save lives. Lung cancer is the biggest cause of cancer death in the UK and worldwide.
The consortium is led by the Universities of Southampton and Leeds, together with healthcare, diagnostics and informatics companies, to test the best way of detecting cancers at a stage when they can still be cured, linking to the NHS England Lung Health Checks programme. In addition to BC Platforms, the research collaborators include Johnson & Johnson, Roche, Oncimmune, Inivata and others.